ABX-IL8: Began Phase IIa trial

Abgenix Inc. (ABGX), Fremont, Calif. Product: ABX-IL8 Business: Autoimmune/Inflammation Therapeutic category: Antibody Target: Interleukin-8 (IL-8) Description: Human monoclonal antibody against IL-8 ...